NOD1 and metabolic disease: Additionally, the majority of GWAS have been performed on Caucasian populations, so it may be beneficial to perform additional GWAS in other ethnic populations with higher risk for metabolic disease, such as Native Americans, Southeast Asians, or African Americans, to determine whether NOD1 and NOD2 variants are genetic risk factors for metabolic dysfunction.